Immucell Corp.

Immucell Corp.
Stock Exchange NASDAQ Stock Market
Market Cap
$46.41 M
Shares Outstanding
7.21 M
Public Float
3.81 M


56 Evergreen Drive
Portland Maine 04103
United States
Employees -
Updated 07/08/2019
ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.


View All

Michael F. Brigham
President, CEO, Secretary, Treasurer & Director
Joseph H. Crabb
Director & Chief Scientific Officer